Show simple item record

dc.creatorRuíz-Garzón J.A. 
dc.creatorCalderón-Ospina C.A. 
dc.date.accessioned2020-05-26T00:00:19Z
dc.date.available2020-05-26T00:00:19Z
dc.date.created2019
dc.identifier.urihttps://repository.urosario.edu.co/handle/10336/23200
dc.description.abstractIntroduction: Therapeutic failure is a public health problem. Although there is abundant theory, a critical review of existing definitions is required. Objective: To critically review the current concept of therapeutic failure, its classification and importance in pharmacovigilance. Materials and methods: Two independent reviewers conducted a systematic search of the existing definitions of treatment failure, as well as the classification systems described in the relevant literature. Based on this information, a critical analysis was carried out and a new consensual definition of therapeutic failure was proposed. Results: The current understanding of therapeutic failure is defective as it does not consider the decrease in drug effect in real life use compared to the premarketing period, where the estimate of efficacy is based on controlled clinical trials. Although the current classification is adequate, both the algorithm of Vaca-González et al. and other tools used to assess pharmacovigilance causality depend on the quality of the report. Conclusions: It is necessary to improve the current definitions of therapeutic failure, as well as the quality of the reports to take full advantage of the classification systems. Pragmatic clinical studies for newly marketed drugs are proposed in order to establish their true effectiveness and safety profile. © 2019, Universidad Nacional de Colombia. All rights reserved.
dc.format.mimetypeapplication/pdf
dc.language.isoeng
dc.relation.ispartofRevista Facultad de Medicina, Vol.67, No.3 (2019); pp. 287-292
dc.relation.urihttps://www.scopus.com/inward/record.uri?eid=2-s2.0-85073716920&doi=10.15446%2frevfacmed.v67n3.65801&partnerID=40&md5=00ca2d53d997531ed626e341196401af
dc.titleConsiderations regarding the reporting and evaluation of therapeutic failure in pharmacovigilance
dc.typearticle
dc.publisherUniversidad Nacional de Colombia
dc.subject.keywordClinical Trials as Topic (mesh)
dc.subject.keywordDrug Resistance
dc.subject.keywordDrug Tolerance
dc.subject.keywordPharmacoepidemiology
dc.subject.keywordPharmacovigilance
dc.rights.accesRightsinfo:eu-repo/semantics/openAccess
dc.type.spaArtículo
dc.rights.accesoAbierto (Texto Completo)
dc.type.hasVersioninfo:eu-repo/semantics/publishedVersion
dc.identifier.doihttps://doi.org/10.15446/revfacmed.v67n3.65801
dc.title.TranslatedTitleConsideraciones acerca del reporte y la evaluación del fallo terapéutico en farmacovigilancia
dc.relation.citationEndPage292
dc.relation.citationIssueNo. 3
dc.relation.citationStartPage287
dc.relation.citationTitleRevista Facultad de Medicina
dc.relation.citationVolumeVol. 67
dc.source.instnameinstname:Universidad del Rosario
dc.source.reponamereponame:Repositorio Institucional EdocUR


Files in this item

Thumbnail

This item appears in the following Collection(s)

Show simple item record